Salarius Pharmaceuticals Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Salarius Pharmaceuticals Inc.
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The Company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
/ 
Others were interested in
See all stocksFrequently asked questions
To buy Salarius Pharmaceuticals Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Salarius Pharmaceuticals Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Salarius Pharmaceuticals Inc. is SLRX:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Salarius Pharmaceuticals Inc. has its primary listing on NASDAQ. You can trade Salarius Pharmaceuticals Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Salarius Pharmaceuticals Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Salarius Pharmaceuticals Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Salarius Pharmaceuticals Inc..